ELU-005

N/A

Report date: 2023/11/03 16:58:33

Base Information

Drug NameELU-005
Drug Alias NameELU-005ELU005
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyeloid cell surface antigen CD33 modulators
TargetsMyeloid cell surface antigen CD33
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesElucida Oncology Inc
China Registration ClassN/A

Develop Information

Active CompaniesElucida Oncology Inc
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A